Research

Studying the health enhancing properties of spirulina

October 4, 2013
AlgaeIndustryMagazine.com

A staple of ancient cultures, spirulina continues to be a popular health supplement around the world.

A staple of ancient cultures, spirulina continues to be a popular health supplement around the world.

Emma Eley writes in Chemistry World that scientists investigating the health enhancing properties of spirulina have identified that its atheroprotective activity may be due to it having a protein with a similar structure to bilirubin.

Spirulina, the blue-green algae taken for hundreds of years as a food supplement, has gained cult superfood status because it is packed full of proteins, polysaccharides and vitamins. It has also sparked a craze of urban gardening – barrels of the edible algae are even being grown on rooftops in Bangkok, Thailand.

Although its atheroprotective effects are well established, scientists have been unsure about the mechanism behind its activity. Now a team – led by Petr Nachtigal at Charles University in Prague – say they are closer to the answer.

Spirulina’s atheroprotective activity was already thought to be due to an algal protein complex called phycocyanobilin (PCB). PCB is structurally related to the human bile pigment bilirubin, which is clinically proven to protect against oxidative-stress related diseases such as atherosclerosis. In humans, bilirubin is made when the enzyme haem oxygenase-1 (HMOX1) catalyses the breakdown of haem. Nachtigal’s team has now shown that PCB can boost HMOX1 mRNA expression and activity in mice.

Although the mechanism by which PCB upregulates the enzyme is still not known, Nachtigal says that HMOX1 expression is a potential atheroprotective pathway. He goes on to add that ‘the underlying mechanism might be Spirulina-induced modulation of the intracellular Nrf2/Keap1 transcriptional system of HMOX1,’ and that they are currently investigating this.

“While this work clearly demonstrates that spirulina has a positive effect on HMOX1 expression and HMOX enzyme activity in endothelial cells, it is not conclusive that PCB is solely responsible for these effects,” says Maria Hayes, an expert in marine bioactives from Teagasc Food Research Centre, Dublin. “It would be interesting to see if other PCB containing cyanobacteria species have similar effects and it would be most interesting to see if these extracts inhibit other enzymes such as platelet activating factor acetylhydrolases which are thought to play a role in inflammation and atherosclerosis.”

Further work from the group will focus on combining spirulina with the most commonly used atherosclerosis drugs, statins.

Read More

More Like This…

HOME Algae Industry Jobs

Copyright ©2010-2013 AlgaeIndustryMagazine.com. All rights reserved. Permission required to reprint this article in its entirety. Must include copyright statement and live hyperlinks. Contact editorial@algaeindustrymagazine.com. A.I.M. accepts unsolicited manuscripts for consideration, and takes no responsibility for the validity of claims made in submitted editorial.

From The A.I.M. Archives

— Refresh Page for More Choices
Heliae, SCHOTT North America and Arizona State University (ASU) have announced a partnership to bring Heliae’s algae production technology to ASU’s algae testbed facility...
Natural carotenoid specialists Piveg Inc., with production facilities based in Celaya, Central Mexico, has announced immediate availability of natural astaxanthin materia...
The University of Greenwich is leading a €10m international project, called the ‘D-Factory,’ to build a biorefinery to develop the microalga Dunaliella as a sustainable r...
In a global scenario where increasing attention is being directed towards issues of sustainability and limited food supplies, algal sources offer immense scope for the ra...
Valensa International and Contract Biotics have announced that Contract Biotics has started construction of an additional six acres of algae production units at the compa...
Technical standards define critical terms and metrics to add wisdom for the algae industry. Agreement among science and business leaders represents possibly the most diff...
“Proterro has reached its Q1 sugar-production pilot milestones,” CEO Kef Kasdin reported at the recent Advanced Biofuels Leadership Conference, in Washington, D.C. “In fo...
Yereth Rosen reports in the Anchorage Daily News that scientists at North Carolina State University’s Plants for Human Health Institute have found extremely high levels o...
A team of six University of Calgary researchers has been awarded funding for their project, Cost Effective Biotechnology for Carbon Capture and Re-Use, based on the conce...
Although the use of whole microalgae in animal diets has long been studied, the 
de-fatted biomass of microalgal species, derived from biofuel production research, has on...
Jamie Radford writes in the Illawarra Mercury that Pia Winberg, from the University of Wollongong, believes that the South Coast of New South Wales, Australia (NSW) is in...
Algae Industry Magazine is pleased to announce a new Algae 101 series by our popular blogger, Mark Edwards, Professor, Arizona State University. The Algae Solutions to Na...
Algae manufacturer Cyanotech Corporation has announced implementing three major initiatives to improve Astaxanthin production at their Kailua Kona, Hawaii-based cultivati...
Steven Mufson reports for the Washington Post that Algenol Biofuels estimates hackers have attempted to break into its computers 39 million times in four months this year...
A recent discovery in the multicellular green alga, Volvox carteri,has revealed the origin of male and female sexes, showing how they evolved from a more primitive mating...
Perth, Western Australia-based Algae.Tec Limited has announced that the Reliance Group has converted the first tranche of options following the positive progress achieved...
In an effort to propel the algae industry forward, the Algae Testbed Public Private Partnership (ATP3) offers a series of hands-on specialized workshops suited for partic...
Following a request from the European Commission, the European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition and Allergies (NDA) was recently asked t...